Pelage Pharmaceuticals, Inc.

Overhead shot of dropper vitamin application on bald scalp, isolated on a clean background, well-lit studio setting, emphasizing effective hair care

Regenerative Hair Loss Treatment Targets Dormant Follicle Stem Cells [Clinical Trial]

Pelage Pharmaceuticals announced the commencement of the Phase 2a trial for PP405, a novel hair loss treatment targeting dormant follicle stem cells.